Case Study – June 12, 2019

Streamlining Publications Development with Real-Time Co-Authoring

A multibillion-dollar global pharmaceutical firm became frustrated with the time-consuming and labor-intensive publication process and wanted to improve it. To achieve its primary goals of finalizing a manuscript more quickly and improving the overall experience for authors, the company decided to use a co-authoring platform to shorten timelines, keep proprietary information secure, and give authors more flexibility to make more thoughtful and thorough contributions.

In this success story, learn how a leading drug company leveraged co-authoring technology to simplify and expedite the manuscript development process.

Download the Resource

Provide your information to download the resource.

By supplying your contact information, you authorize Within3 to contact you with further information.